Meritage Portfolio Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,462
Closed -$9.65M 331
2024
Q3
$9.65M Sell
30,462
-290
-0.9% -$103K 0.59% 37
2024
Q2
$11.5M Buy
30,752
+19,351
+170% +$6.53M 0.73% 25
2024
Q1
$3.95M Sell
11,401
-20,988
-65% -$7.95M 0.25% 125
2023
Q4
$14.8M Buy
32,389
+14,778
+84% +$7.28M 0.98% 20
2023
Q3
$8.57M Sell
17,611
-91
-0.5% -$42.8K 0.63% 37
2023
Q2
$7.92M Buy
+17,702
New +$8.91M 0.56% 44
2014
Q1
Sell
-51,570
Closed -$5.32M 204
2013
Q4
$5.32M Sell
51,570
-2,435
-5% -$239K 0.66% 53
2013
Q3
$5.04M Buy
54,005
+27,055
+100% +$2.48M 0.65% 54
2013
Q2
$2.27M Buy
+26,950
New +$2.13M 0.33% 149

Other funds holding HUM

Meritage Portfolio Management's HUM Position: Q4 2024 in Review

Meritage Portfolio Management sold out of Humana (HUM) in Q4 2024, closing a stake of 30,462 shares — an estimated $9.65M sold.

Meritage Portfolio Management first reported a position in HUM in Q2 2013 and held it in 9 quarters. The position peaked at $14.8M in Q4 2023. 878 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Meritage Portfolio Management reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Meritage Portfolio Management sold 30,462 Humana shares in Q4 2024, an estimated $9.65M.
  • Meritage Portfolio Management first reported a position in Humana in Q2 2013 and held it in 9 quarters.
  • Meritage Portfolio Management's Humana position peaked at $14.8M in Q4 2023.
  • 878 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Meritage Portfolio Management's 13F filing for Q4 2024, filed 27 Jan 2025.